STOXX 600 up 0.4%
Saab rallies after results, lifts defence
GSK slides on FDA advisory update
Wall St futures higher
Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at markets.research@thomsonreuters.com
STOXX HEADS HIGHER, SET FOR WEEKLY GAIN
Europe's STOXX 600 is up 0.4% on Friday, moving into positive territory for the week, although a raft of earnings are painting a mixed picture.
Sweden's Saab SAABb.ST is up 13% after its earnings, taking year-to-date gains for the defence group to 131%. The STOXX Europe Aerospace and Defence Index .SXPARO is up 0.8% on Friday and up 57% for the year.
Compatriot Electrolux ELUXb.ST is down 14% as the appliance maker flagged weak performance in Europe.
Breadth is positive with advancers outpacing decliners in the pan-European benchmark by about 3.6:1.
Elsewhere, GSK GSK.L shares are slumping over 6% after its blood cancer drug Blenrep failed to win backing from a U.S. FDA advisory panel, with a formal decision expected next week.
Here's your opening snapshot:
(Samuel Indyk)
*****
EARLIER LIVE MARKETS POSTS:
EUROPE BEFORE THE BELL: FUTURES HIGHER AS CONSUMER HOLDS UP CLICK HERE
STOCKS BUOYANT BUT JAPAN VOTE BRINGS RISK CLICK HERE
Japan's core inflation slows in June https://reut.rs/3GU4YwJ
G10 currency moves against the US dollar https://reut.rs/44Uk516
European shares rise, STOXX set for weekly gain https://reut.rs/3IBF6pQ
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.